Big Pharma — sleep apnoea

COVID-19 patients with sleep apnoea could be at additional risk

COVID-19 sleep apnoea

COVID-19 patients with sleep apnoea could be at additional risk

COVID-19 patients with sleep apnoea could be at additional risk   Relationship between obstructive sleep apnoea and poorer outcomes from COVID-19 identified in systematic review of studies by University of Warwick Researchers advise that people with obstructive sleep apnoea should take the necessary precautions to reduce their exposure and follow their treatment plan diligently 5 million people in the UK currently diagnosed with the condition, but up to 85% of people could be undiagnosed Researchers call for better recording and more data on the condition   People who have been diagnosed with obstructive sleep apnoea could be at increased risk...

Leer más →